Predictive imaging biomarkers relevant for functional and anatomical outcomes during ranibizumab therapy of diabetic macular oedemaBianca S. Gerendas, Ursula Schmidt‐Erfurth, Jan Lammer et al.|British Journal of Ophthalmology|2017Cited by 95
Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year resultsKatharina Kriechbaum, Ursula Schmidt‐Erfurth, Sonja Prager et al.|Eye|2013Cited by 54